ClinConnect ClinConnect Logo
Search / Trial NCT06892119

Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation

Launched by HOSPITAL UNIVERSITARIO DR. JOSE E. GONZALEZ · Mar 21, 2025

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

The objective of this study is to demonstrate that the use of a low dose of the generic form of a drug called plerixafor is effective in increasing the amount of hematopoietic cells (stem cells) in your blood, which will then be collected for your transplant. Plerixafor is a very effective medicine that is already used for this purpose, however its high cost limits its use in all patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with lymphoma or multiple myeloma who are candidates for autoHSCT
  • Patients \> 18 years old who signed our informed consent
  • Normal CBC count (Hb \> 10, WBC 4.0-11.00, plt \> 100,000)
  • Exclusion Criteria:
  • Patients with HIV, Hepatitis C, Hepatitis B diagnosis
  • Pregnant women

About Hospital Universitario Dr. Jose E. Gonzalez

Hospital Universitario Dr. José E. González is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. Located in Monterrey, Mexico, the hospital is affiliated with the University of Nuevo León, fostering a collaborative environment that integrates education, patient care, and scientific inquiry. With a commitment to improving patient outcomes, the hospital actively conducts clinical trials across various medical disciplines, leveraging its state-of-the-art facilities and a multidisciplinary team of experts to explore new therapies and enhance treatment options for diverse patient populations.

Locations

Monterrey, Nuevo Leon, Mexico

Patients applied

0 patients applied

Trial Officials

Olga G Cantú-Rodríguez, MD

Study Chair

Universidad Autónoma de Nuevo León

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported